Your browser doesn't support javascript.
loading
Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants
Acta Pharmaceutica Sinica B ; (6): 3187-3194, 2022.
Article in English | WPRIM | ID: wpr-939921
ABSTRACT
The heparin polysaccharide nanoparticles block the interaction between heparan sulfate/S protein and inhibit the infection of both wild-type SARS-CoV-2 pseudovirus and the mutated strains through pulmonary delivery.Image 1.

Full text: Available Index: WPRIM (Western Pacific) Language: English Journal: Acta Pharmaceutica Sinica B Year: 2022 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Language: English Journal: Acta Pharmaceutica Sinica B Year: 2022 Type: Article